Corrigendum for HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review
Corrigendum for HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review
José L. Blanco-Arévalo 1, Miguel García-Deltoro 2, Miguel Torralba 3, Manuel Vélez-Díaz-Pallarés 4, Antonio Castro 5, Darío Rubio-Rodríguez 6, Carlos Rubio-Terrés 6
1 Infectious Diseases and AIDS Unit, Hospital Clinic, Barcelona, Spain; 2 Infectious Diseases Unit, Hospital General Universitario de Valencia, Valencia, Spain; 3 Internal Medicine Department, Hospital Universitario de Guadalajara, IDISCAM, Guadalajara, Jalisco; 4 Department of Pharmacy, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain; 5 Gilead Sciences SL, Madrid, Spain; 6 Health Value SL, Madrid, Spain
*Correspondence: Antonio Castro, Email not available
